Nimat Alam, MD
Geriatric Medicine · Odessa, TXNPI 1972737898
Payments from drug & device makers
Across 9 payments — averaging $61.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$117
- Shire North American Group Inc$90
- Pacira Therapeutics, Inc.$87
- Eisai Inc.$85
- Acadia Pharmaceuticals Inc$77
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$65
- plus $32 from 2 others
What the payments were for
- Food & beverage$555100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 1 | $117 |
| Shire North American Group Inc | 1 | $90 |
| Pacira Therapeutics, Inc. | 2 | $87 |
| Eisai Inc. | 1 | $85 |
| Acadia Pharmaceuticals Inc | 1 | $77 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $65 |
| Boston Scientific | 1 | $17 |
| Philips North America LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$117
How this compares
$555 in reported general payments places this provider in the 70th percentile of 275 geriatric medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 12 | $20,092 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 13 | $7,974 |
| EliquisApixaban | 13 | $7,648 |
| Budesonide ErBudesonide | 13 | $7,310 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $2,074 |
| Memantine Hcl ErMemantine Hcl | 20 | $1,502 |
| Gabapentin | 117 | $1,276 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 13 | $1,254 |
| Humalog Kwikpen U-100Insulin Lispro | 19 | $1,248 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 26 | $947 |
| Pravastatin Sodium | 58 | $841 |
| Potassium Chloride | 28 | $611 |
| Levothyroxine Sodium | 84 | $610 |
| Mirtazapine | 22 | $537 |
| Buspirone Hcl | 20 | $491 |
Paid to pharmacies, not to this prescriber.
Other geriatric medicine in Odessa
- Anna Marie FranciscoOdessa$2K
- Diana KerwinDallas$12.7M
- Mauricio Gonzalez-AriasAustin$825K
- Eberenne IgbokwePearland$124K
- Janice KneblFort Worth$54K
- David SmithBrownwood$19K
- Alejandro ArizmendiHelotes$15K
- Rosa VizcarraSan Antonio$9K
- George TaffetHouston$9K
- John CarrollCorpus Christi$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.